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Abstract
 
Natural killer (NK) cells are an important early mediator of host immunity to murine cytomega-
lovirus (MCMV) infection. However, MCMV has evolved mechanisms to elude recognition and
clearance by NK cells. We have identified an MCMV immune evasion protein that impairs
NKG2D-mediated NK cell antiviral activity. Infection of BALB/c 3T3 cells with the Smith
strain of MCMV resulted in strong down-regulation of H60, a high affinity ligand for NKG2D,
from the surface of virus-infected cells. The MCMV m155 protein specifically down-regulated
H60 without affecting expression of the other known NKG2D ligands, RAE-1 and MULT-1.
Treatment with the proteasome inhibitors lactacystin or epoxomicin reversed m155 down-
regulation of H60. An MCMV mutant virus lacking m155 was severely attenuated in BALB/c
mice; however, treatment with neutralizing anti-NKG2D monoclonal antibody or with NK-
depleting anti-asialo GM1 antisera restored virulence of the mutant virus. Thus, down-regulation
of H60 by m155 is a powerful mechanism of inhibiting NKG2D-mediated antiviral function.
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Introduction
 
A remarkable feature of CMVs is their ability to persist for
the lifetime of the host despite a fully functional immune
system. This occurs through the concerted activity of mul-
tiple viral immune evasion molecules, termed immunoevasins
(1), which selectively target essential components of the
immune response to pathogens and undermine immune
surveillance mechanisms. Several human and mouse CMV
proteins have been identified that modulate MHC class I
expression in infected cells and effectively inhibit antigen
presentation to CTLs (2).
CMV can also evade NK cells, which are an important
component of the innate immune response to both murine
CMV (MCMV) and human CMV (HCMV; references 3
and 4). A protective role of the NKG2D receptor in the re-
sponse to CMV has been revealed by examining the effect
of CMV infection on NKG2D ligands, several of which are
down-regulated during infection. In humans, there are two
families of ligands for NKG2D, MICA and MICB (5), and
the UL16-binding proteins (ULBPs), ULBP-1, ULBP-2,
ULBP-3, and ULBP-4 (6). An HCMV glycoprotein,
UL16, was recently found to sequester MICB, ULBP-1,
and ULBP-2 intracellularly during HCMV infection and
decrease susceptibility to NK cell–mediated cytotoxicity
(7, 8). Ligands for murine NKG2D include retinoic early
inducible-1 gene (RAE-1)
 
 
 
, RAE-1
 
 
 
, RAE-1
 
 
 
, RAE-1
 
 
 
,
and RAE-1
 
 
 
, H60 (9, 10), and MULT-1 (11). RAE-1
proteins are down-regulated during MCMV infection by
the 
 
m152
 
 gene product gp40, which functionally impairs
NKG2D-mediated NK cell recognition of infected cells
(12, 13). Because H60 is not affected by gp40, we set out
to determine if MCMV infection also impacts expression of
H60 on virus-infected cells.
 
Materials and Methods
 
Mice.
 
BALB/c mice were purchased from The Jackson Lab-
oratory. Experiments involving mice were conducted using pro-
tocols approved by the University of California, Berkeley, Office
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of Animal Care and Use Committee and the University of Cali-
fornia, San Francisco, Committee on Animal Research.
 
Cells and Transfectants.
 
Because the reported H60 cDNA se-
quence (14) lacked a stop codon, we engineered a stop codon 5
 
 
 
to the poly-A track. H60, MULT-1, and RAE-1 cDNAs were
cloned into the pMX-pie vector, which contains an internal ri-
bosome entry site (IRES) element followed by a cDNA encoding
enhanced GFP. In a 1:3 ratio, vectors encoding H60, MULT-1,
or RAE-1 were mixed with either pMX-neo alone or pMX-neo
vector encoding MCMV m155 cDNA. Transient cotransfection
of 293T cells was performed as described previously (13). Cells
were analyzed by flow cytometry 48 h after transfection.
BALB/c 3T3 cells were obtained from the American Type
Culture Collection. CT498 transfectants were generated by ret-
roviral transduction of BALB/c 3T3 cells. A plasmid encoding
MCMV m155 cDNA in pMX-neo was transfected into Phoenix
A ecotrophic viral-packaging cells using Lipofectamine 2000 Re-
agent (Invitrogen). After 48 h, the virus was used to infect BALB/c
3T3 cells.
 
Viruses.
 
MCMV Smith, DMS94.5 (
 
 
 
m150-165; reference
15), and 
 
 
 
MC96.24 (
 
 
 
m152; reference 16) viruses were pro-
vided by A. Hill (Oregon Health Sciences University, Portland,
OR). Rvm155 is an MCMV mutant lacking m155 (Dm155; see
below, Fig. S1) and Rqm155-Rq155 is the revertant of Rvm155
with a functional m155 gene restored (17, 18).
 
Flow Cytometry.
 
3T3 cells were infected with MCMV at a
multiplicity of infection (MOI) of 2 and analyzed after 48 h of
culture. mAb 186107 was used to detect RAE-1
 
 
 
, RAE-1
 
 
 
,
RAE-1
 
 
 
, RAE-1
 
 
 
, and RAE-1
 
 
 
, mAb 205310 was used to de-
tect H60, and mAb 237104 was used to detect MULT-1. The
205310 and 237104 mAbs were generated by immunizing LOU/
MWS1 rats with Ig fusion proteins containing the extracellular
domains of H60 and MULT-1, respectively. mAb 205310 is spe-
cific for H60 and does not cross-react with MULT-1 or RAE-1,
as determined by testing on a panel of transfectants expressing
H60, MULT-1, or RAE-1. Mouse 
 
 
 
1 integrin (CD29) was de-
tected with HM
 
 
 
1-1 mAb (BD Biosciences). All samples were
treated with propidium iodide to exclude dead cells during analy-
sis. Flow cytometry was performed with a FACSCalibur (BD Im-
munocytometry Systems).
 
Proteasome Inhibitors and Immunoprecipitation.
 
3T3 or CT498
cells were left untreated or treated with 10 
 
 
 
M lactacystin or 10
 
 
 
M epoxomicin (both from Sigma-Aldrich) for 14 h. Cells were
then either analyzed by flow cytometry or lysed in 1% NP-40
and used for immunoprecipitation. Lysates were also made from
uninfected 3T3 cells or 3T3 cells infected with Rvm155 or
Rqm155. H60 was immunoprecipitated with anti-H60 mAb
205326. Proteins were separated by 8% SDS-PAGE and analyzed
by Western blot analysis. H60 was detected with biotinylated
anti-H60 mAb 205310 and 
 
 
 
1 integrin was detected by anti-
CD29 mAb 9EG7 followed by peroxidase-conjugated streptavi-
din or anti–rat IgG, respectively, and ECL-developing reagent
(Amersham Biosciences).
 
In Vivo MCMV Infection.
 
2 d before infection, mice were in-
jected i.p. with either 100 
 
 
 
g of rat anti–mouse NKG2D mAb
CX5 (19) or control rat IgG (eBioscience). 1 d before infection
and on the day of infection, a group of mice was injected i.p.
with 100 
 
 
 
g of anti-asialo GM1 (Wako Chemicals). Mice were
infected i.p. with 10
 
5 
 
PFUs or 2 
 
  
 
10
 
5 
 
PFUs of Smith, Rvm155
(Dm155), or Rqm155 (revertant) virus. Spleens and livers were
harvested on day 3 after infection. Organs were homogenized,
serial dilutions were made, and a standard plaque assay was per-
formed in triplicate on 3T3 cells. Viral titers are expressed as
PFUs per milliliter of tissue homogenate.
When injected in vivo, anti-NKG2D mAb CX5 blocked and/
or modulated NKG2D, but did not deplete NK cells (19). Anti-
asialo GM1 was used to deplete NK cells. To confirm modulation
of NKG2D on NK cells from anti-NKG2D–treated mice, and NK
cell depletion in anti-asialo GM1-treated mice, spleens from anti-
body-treated mice were collected on day 3 after infection and ana-
lyzed for NKG2D expression and the percentage of NK cells.
 
Online Supplemental Material.
 
Construction of the m155 de-
letion mutant virus is depicted in Fig. S1. The finding that m155
does not substantially affect H60 transcription in shown in Fig.
S2. Figs. S1 and S2 are available at http://www.jem.org/cgi/
content/full/jem.20040583/DC1.
 
Results and Discussion
 
MCMV Infection Down-regulates H60.
 
Infection of 3T3
cells with MCMV results in strong down-regulation of RAE-1
by gp40 encoded by the 
 
m152
 
 gene (12, 13). However,
gp40 did not down-regulate H60, another high affinity
ligand for NKG2D. To address whether MCMV affects
H60, we infected 3T3 cells, which constitutively express
H60 on the cell surface, with MCMV. 48 h after infection,
we analyzed cells for H60. We observed a marked decrease
in the level of cell surface H60 after infection (Fig. 1).
To identify the MCMV gene product that down-regu-
lates H60, we infected 3T3 cells with a panel of deletion
mutant viruses. After infection with a deletion mutant lack-
ing the m150-m165 open reading frames (ORFs; 
 
 
 
m150-
165), H60 expression was partially restored (Fig. 1). A dele-
tion mutant virus lacking only m152 retained the ability to
down-regulate H60. These data indicate that H60 is down-
regulated by a gene product within the m150-165 block,
but is not affected by m152.
 
MCMV m155 Down-regulates H60, But Not RAE-1 or
MULT-1.
 
By transiently transfecting human 293T cells
with vectors encoding H60 and vectors encoding each of
Figure 1. MCMV infection
down-regulates H60. 3T3 cells
were infected with wild-type
MCMV (Smith), DMS94.5
( m150-165), or  MC96.24
( m152) viruses at an MOI of 2.
48 h after infection, cells were
stained with control IgG2a (dot-
ted histograms) or anti-H60 mAb
(bold histograms). 
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the MCMV ORFs, we were able to examine the effect of
individual MCMV gene products on H60 expression. H60
was expressed in a vector containing an IRES–enhanced
GFP element, permitting visualization of GFP
 
  
 
cells that
express H60 upstream of the IRES. Cotransfection of H60
with m155 resulted in a substantial decrease in H60 ex-
pressed on the surface (Fig. 2 A). We also considered the
possibility that m155 may affect other ligands for NKG2D,
such as RAE-1 or MULT-1. m155 did not affect of any of
the other known NKG2D ligands because expression of
these molecules was not changed by cotransfection with
m155 (Fig. 2 A). In addition, m155 did not cause global
down-regulation of cell surface receptors because the level
of MHC class I was unaltered on the surface of 293T cells
transfected with m155 (not depicted).
Zhan et al. (17) previously described an MCMV mutant,
Dm155, in which the m155 ORF was disrupted by ran-
dom insertion of a transposon. This m155-deficient virus
demonstrated normal viral replication in vitro, but was se-
verely attenuated in SCID mice (18). To assess the effect of
m155 on H60 in cells infected with MCMV, we infected
3T3 cells with the Dm155 virus and a revertant virus that
restored m155 expression. The Dm155 virus failed to effi-
ciently down-regulate H60, whereas H60 down-regulation
was largely restored by infection with the revertant virus
(Fig. 2 B). Therefore, m155 plays a significant role in H60
Figure 2. m155 down-regu-
lates H60, but not RAE-1 or
MULT-1. (A) 293T cells were
transfected with a vector encod-
ing H60, MULT-1, or RAE-1,
and either a control vector (dotted
histograms) or a vector encoding
m155 (bold histograms). 48 h after
transfection, cells were stained
with anti-H60, anti–MULT-1,
or anti–RAE-1 mAbs. H60,
MULT-1, and RAE-1 were en-
coded on vectors carrying an
IRES-GFP, whereas a non-GFP
vector was used for m155 cDNA
and for the control vector. His-
tograms show GFP  populations.
Results are representative of
three independent experiments.
(B) 3T3 cells were infected with
Rqm155-Rq155 (the m155 re-
vertant virus) or Dm155 ( m155)
virus at an MOI of 2. 48 h after
infection, cells were stained with
control IgG2a (dotted histo-
grams), anti-H60, anti–RAE-1,
anti–MULT-1, or anti– 1 inte-
grin (bold histograms). This ex-
periment was performed several
times with comparable results. 
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down-regulation. Because the level of H60 on Dm155-
infected cells was not completely restored to the level of
H60 on uninfected 3T3 cells, other MCMV gene products
may also contribute to H60 down-regulation. To examine the
expression of other NKG2D ligands after infection with
Dm155 and revertant virus, we stained cells infected with
these viruses for RAE-1 and MULT-1. Consistent with the
previous finding that MCMV infection down-regulated
RAE-1, the revertant virus strongly down-regulated RAE-
1 (Fig. 2 B). Interestingly, we also observed down-regula-
tion of MULT-1 after infection with wild-type (not de-
picted) and the revertant virus (Fig. 2 B), which is the first
evidence that MULT-1 is also impacted by MCMV. Infec-
tion of 3T3 cells with Dm155 did not, however, restore
cell surface expression of either RAE-1 or MULT-1, again
indicating that m155 does not impact expression of these
glycoproteins. To demonstrate that MCMV infection did
not cause nonspecific down-regulation of cell surface re-
ceptors, we stained the cells for expression of 
 
 
 
1 integrin,
which was comparable on uninfected and infected cells
(Fig. 2 B). Thus, m155 selectively targets H60.
Unlike gp40, which modulates expression of both RAE-1
and MHC class I, m155 does not affect expression of MHC
class I. Expression of H-2D
 
d 
 
and H-2K
 
d 
 
on RAW264.7
cells was unaltered by transient transfection with a plasmid
encoding m155, implying that m155 does not affect these
haplotypes (not depicted). This is consistent with the find-
ing that the products of the 
 
m04
 
,
 
 m06
 
, and 
 
m152
 
 genes are
the only MCMV immunoevasins that substantially impact
MHC class I (20).
Figure 3. Proteasome inhibition reverses m155 down-regulation of H60. (A) Lysates were generated from untreated cells or cells treated with 10  M
lactacystin for 14 h and immunoprecipitated with control IgG2a or anti-H60 mAb. Western blotting was performed for H60 or  1 integrin protein.
(B) Untreated 3T3 or CT498 cells (3T3 cells stably transfected with m155) and 3T3 or CT498 cells treated with 10  M lactacystin or 10  M epoxomicin
for 14 h were stained with a control IgG2a (dotted histograms), anti-H60, or anti–RAE-1 mAbs (bold histograms) and propidium iodide. Histograms
show propidium iodide–negative cells ( 95% of total cell population). (C) Lysates were generated from uninfected 3T3 cells, 3T3 cells infected with
Rvm155, or 3T3 cells infected with Rqm155, and immunoprecipitated and Western blotted as described in B. 
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m155 Down-regulates H60 via a Proteasome-dependent Mech-
anism.
 
In addressing the mechanism by which m155
down-regulates H60, we considered the possibility that
m155 may affect H60 transcription. However, when we
analyzed H60 RNA levels in 3T3 cells compared with 3T3
cells stably transfected with m155 (designated CT498 cells),
we found a less than twofold difference in H60 transcrip-
tion (Fig. S2, which is available at http://www.jem.org/
cgi/content/full/jem.20040583/DC1). This is not surpris-
ing, considering that 
 
m155
 
 encodes a potential membrane
glycoprotein. Although H60 transcription was not substan-
tially affected by expression of m155, H60 protein was
strongly down-regulated from the surface of cells express-
ing m155 (Figs. 2 A and 3 B). We then hypothesized that
m155 may cause degradation of H60. To examine this pos-
sibility, we treated 3T3 and CT498 cells with lactacystin, a
cell-permeable, irreversible proteasome inhibitor, and im-
munoprecipitated H60 from lysates of treated or untreated
cells. As revealed by Western blotting, an 
 
 
 
80-kD band,
representing H60, was immunoprecipitated from lysates of
3T3 cells (Fig. 3 B). No H60 protein was detected when
lysates were immunoprecipitated with a control rat IgG2a,
indicating that the 80-kD band is specific for H60. In ly-
sates from CT498 cells, the 80-kD band was no longer
present, consistent with the absence of H60 from the sur-
face of these cells. However, treatment of CT498 cells with
lactacystin restored H60 protein. We also observed restora-
tion of H60 protein in lysates from CT498 cells treated
with epoxomicin, another specific inhibitor of the protea-
some (not depicted).
We also examined whether H60 protein was restored on
the cell surface of CT498 cells after treatment with lactacys-
tin or epoxomicin. We observed that treatment with either
proteasome inhibitor resulted in high expression of H60 on
the surface of CT498 cells (Fig. 3 B). As a control, we ana-
lyzed RAE-1 expression on cells treated with the inhibitors
and found that it was essentially unaffected. Thus, specific
inhibition of the proteasome restored both intracellular and
cell surface H60 in cells expressing m155, suggesting that
the m155 gene product down-regulates H60 via a protea-
some-dependent mechanism. It remains unclear how H60 is
restored inside cells and on the cell surface by proteasome
inhibition. Proteasome inhibitors may prevent direct degra-
dation of H60 by the proteasome, or may serve to stabilize
H60 in an indirect manner. The latter possibility has been
described for the stabilization of MHC class I complexes in
cells expressing KSHV K3, which directs internalization of
MHC class I from the surface of KSHV-infected cells (21).
Because the ubiquitin–proteasome system has been impli-
cated in regulation of the endocytic pathway (21), it might
be involved in the down-regulation of H60 from the sur-
face of MCMV-infected cells.
To examine H60 protein during MCMV infection, we
infected 3T3 cells with the Dm155 or revertant virus and
analyzed H60 protein in lysates from these cells by immu-
noprecipitation and Western blotting. Consistent with the
cell surface down-regulation of H60 by MCMV infection,
H60 was undetectable in lysates of 3T3 cells infected with
revertant virus (Fig. 3 C). However, H60 protein was par-
tially restored in lysates from cells infected with Dm155 vi-
Figure 4. Depletion of NK cells or
blockade of NKG2D restores virulence
of Dm155. (A) BALB/c mice were in-
jected i.p. with control rat IgG, anti-
asialo GM1 antisera, or anti-NKG2D
mAb (CX5). After antibody treatment,
mice were infected with 105 PFUs (A)
or 2   105 PFUs (B) of Smith, Rqm155
(revertant), or Rvm155 (Dm155). 3 d
after infection, spleens and livers were
harvested. Plaque assays were performed
on organ homogenates to determine viral
titers. In each experiment, three mice
were used in each experimental group
and error bars represent the standard de-
viation of the viral titers from these
three mice. Three independent experi-
ments were performed and data from
two experiments using 2   105 PFUs
were combined for presentation in B.
The limit of detection was 1 PFU/ml
organ homogenate. 
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rus. These data indicate that MCMV infection down-regu-
lates H60 protein both from the cell surface and inside cells,
and that this effect can be attributed to m155.
 
NKG2D-mediated Protection against MCMV Is Impaired by
m155.
 
We hypothesized that NK cell recognition of vi-
rus-infected cells may be impaired by m155. Therefore, we
examined the significance of H60 down-regulation during
MCMV infection in vivo. Before infection of BALB/c
mice, which express functional H60 (14), we treated mice
with a control rat IgG mAb, a neutralizing anti-NKG2D
(CX5) mAb, or an NK cell–depleting anti-asialo GM1 an-
tisera. CX5 mAb blocks the binding of NKG2D to its
ligands and modulates the NKG2D receptor from the sur-
face of NK cells, but does not deplete NK cells (22),
thereby allowing us to directly examine the role of the
NKG2D receptor in the immune response to MCMV. To
investigate the total contribution of NK cells to the MCMV
immune response, we depleted NK cells using anti-asialo
GM1 antisera. After antibody treatment, mice were in-
fected i.p. with 10
 
5 
 
PFUs of virus per mouse (Fig. 4 A) or
with 2 
 
  
 
10
 
5 
 
PFUs (Fig. 4 B) per mouse of wild-type
Smith, Dm155, or the m155 revertant virus. Because pre-
vious studies have implicated NK cells in the control of
MCMV predominantly in the liver and spleen and early
during infection, viral titers in these organs were deter-
mined on day 3 after infection.
In both the spleen and liver of control rat IgG-treated
mice, the Dm155 virus showed marked attenuation (Fig.
4), consistent with previous observations that the Dm155
virus is severely attenuated in growth in multiple organs of
SCID mice (18). After treatment of mice with either anti-
asialo GM1 or anti-NKG2D, however, viral titers in the
spleens of Dm155-infected mice were almost identical to
titers of the wild-type and revertant viruses. In the livers of
mice treated with anti-NKG2D, titers of Dm155 virus
were identical to wild-type and revertant viruses in mice
infected with 10
 
5 
 
PFUs (Fig. 4 A) and slightly higher than
titers of wild-type and revertant viruses in mice infected
with 2 
 
  
 
10
 
5 
 
PFUs (Fig. 4 B). Interestingly, in mice de-
pleted of NK cells with anti-asialo GM1, the viral titers in
the livers of Dm155-infected mice were slightly higher
than viral titers of wild-type and revertant viruses. Collec-
tively, these data indicate that NK cells play a critical role
in the control of the Dm155 virus, and that this protection
is predominantly mediated by NKG2D. Thus, m155 down-
regulation of H60 is an important mechanism of MCMV
evasion of NK cell immune surveillance.
An emerging theme in the study of MCMV immune
evasion is the discovery of viral mechanisms of modulating
NK cell immunity. In addition to encoding several MHC
class I modulators, MCMV expresses at least two proteins
committed to down-regulation of NKG2D ligands, and
these proteins have specificity for different ligands. These
data indicate that NKG2D plays a significant role in the
host immune response to MCMV and that the virus has
evolved mechanisms to counter this pathway. The ability
of the m152 and m155 gene products to down-regulate the
RAE-1 and H60 proteins, respectively, from the surface of
infected cells is clearly advantageous to the virus during
MCMV infection because deletion mutant viruses lacking
these genes are less virulent (16, 17). However, virulence
of both deletion mutant viruses is restored by treatment of
mice with anti-NKG2D mAb. Therefore, blocking NKG2D
recognition of its ligands during MCMV infection confers
a distinct survival advantage to the virus.
During the course of MCMV infection, the NKG2D
ligands might be expressed on different cells types or with
different kinetics. Although expression of RAE-1 is low or
absent on healthy adult tissues, MCMV infection of perito-
neal macrophages strongly induces transcription of the
 
RAE-1
 
 genes (13). H60 and MULT-1 transcripts, how-
ever, were not induced by MCMV infection of macro-
phages. Given the large number of NKG2D ligands, it is
possible that they are differentially regulated in different
cell types, thereby providing nonredundant functions. For
this reason, perhaps it is not surprising that MCMV en-
codes multiple immunoevasins that modulate expression of
the NKG2D ligands.
We have defined a function for the MCMV 
 
m155
 
 gene
product in evasion of NK cell immune surveillance. By
specifically down-regulating H60 from the surface of virus-
infected cells, the m155 protein prevents the interaction
between H60 and the NKG2D receptor and inhibits NK
cell recognition and clearance of infected cells.
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